期刊文献+

HPLC法测定佐米曲普坦的含量及有关物质 被引量:4

Methodology for determination of zolmitriptan content and its impurities by HPLC
下载PDF
导出
摘要 目的:建立HPLE法测定佐米曲普坦的含量及纯度。方法:采用Zorbax SB-C18色谱柱,分别以甲醇:0.025mol/L磷酸二氢钾(16:84)和甲醇:0.025 mol/L磷酸二氢钾:三乙胺(25:75:0.5,pH=3.5)为流动相,流速为1mL/min,在检测波长为220nm处检测。结果:本品在0.01mg/mL^0.15mg/mL浓度范围内呈直线关系,本品中杂质的最小检测限为0.01%。对4批样品进行检测均未检出杂质,而粗品检出明显杂质。结论:本方法可用于含量测定和有关物质的检查。 Objective: To develop high pressure liquid chromatography (HPLC) in order to detect the content and purity of zolmitriptan. Methods: Using ODS - C18 column,methanol;0. 025 mol/L KH2PO4 (16: 84)and methanol:0.025 mol/L KH2PO4:triethylamine(25:75:0. 5, pH = 3. 5) as mg/mL mobile phase, at a flow rate of 1mL/min, wavelength of detector was 220nm. Results: There is a good linear relationship within the range of 0.01mg/mL - 0. 15mg/mL( r = 0. 9999) .It was found that the minimum detective limits of the impurities were 0.01%.Four batches of zolmitriptan synthesized by our institute were analyzed and no impurities were found, but obvious impurities were delected in crude product samples. Conclusion: The method established in our experiment can be used to detect the zolmitriptan drug content and the impurities.
出处 《中国药物应用与监测》 CAS 2004年第2期30-32,共3页 Chinese Journal of Drug Application and Monitoring
关键词 高效液相色谱法 佐米曲普坦 含量 有关物质 HPLC Zolmitriptan Content Related substances
  • 相关文献

参考文献3

二级参考文献4

  • 1王好山 李伟章.依来曲坦与舒马曲坦药效学比较研究[J].国外医学:药学分册,2000,27(4):255-255.
  • 2Hans-Christoph Diener,Holger Kaube,Volker Limmroth.A practical guide to the management and prevention of migraine[].Drugs.1998
  • 3Ngo J,Mealy N,Castaner J.Zolmitriptan[].Drugs of the Future.1997
  • 4王好山,董永明.曲坦类抗偏头痛药物的研究进展[J].国外医学(药学分册),2000,27(3):162-166. 被引量:13

共引文献8

同被引文献22

  • 1谭玲,张姗姗,张相林.佐米曲普坦片的人体生物等效性研究[J].中国药房,2005,16(16):1240-1242. 被引量:3
  • 2赵大庆,高明.pH值调节法制备壳聚糖空白微球[J].中国新药杂志,2006,15(17):1461-1463. 被引量:7
  • 3赵刚,苏庆,李静,田长青,孟晓东.治疗偏头痛药佐米曲普坦制剂的研究进展[J].中国新药杂志,2007,16(11):836-839. 被引量:7
  • 4石杰,史犇,吴拥军,吴予明,龚炜.HPLC测定佐米曲普坦片的含量[J].华西药学杂志,2007,22(5):588-589. 被引量:3
  • 5SINHA V R, SINGLA A K, W ADHA WAN S, et al. Chitosan microspheres as a potential carrier for drugs [J]. Int J Pharm, 2004,274(1-2): 1-33.
  • 6ELT O, BURl P, GURNY R. Chitosan , A unique polysaccharide for drug delivery [J]. Drug Dev Ind Pharm, 1998,24 ( 11 ) : 979-993.
  • 7ALHALAWEH A, ANDERSSON S, VELAGA S P. Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery [J]. Eur J Pharm Sci, 2009, 38(3) :206-214.
  • 8FRANSEN N, BJORK E, NYSTROM C. Development and characterisation of interactive mixtures with a fine-particulate mucoadhesive carrier for nasal drug delivery [J]. Eur J Pharm Biopharm, 2007,67(2) :370-376.
  • 9LIM S T, MARTIN G P, BERRY D J, et al. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan [J]. J Controlled Release, 2000, 66(2-3): 281-292.
  • 10ZENG X M, MARTIN G P, TEE S K, et al. The role of fine particle lactose on the dispersion and deaggregation of salbutamol sulphate in an air stream in vitro [J]. Int J Pharm, 1998, 176 (1 ) : 99-110.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部